Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst

FEBS Lett. 2007 Apr 3;581(7):1509-13. doi: 10.1016/j.febslet.2007.03.008. Epub 2007 Mar 13.

Abstract

Carbamylation is a post-translational modification of proteins characterized by the binding of cyanate to amino groups, increased in renal failure. Pathophysiological consequences of carbamylation and adverse effects of carbamylated proteins on cell functions are poorly understood. We studied the influence of carbamylated albumin on polymorphonuclear neutrophil (PMN) O(2)(-) production. Carbamylated albumin significantly decreased O(2)(-) production in PMNs stimulated by type I collagen, but not by phorbol 12-myristate 13-acetate or tumor necrosis factor-alpha. This effect was related to inhibition of p(125)FAK phosphorylation. Such an alteration of neutrophil oxidative functions might explain characteristic complications of renal failure, such as increased occurrence of inflammation or infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbamates / pharmacology*
  • Focal Adhesion Kinase 1 / metabolism
  • Humans
  • Neutrophils / drug effects*
  • Oxygen / analysis
  • Oxygen / metabolism
  • Phosphorylation / drug effects
  • Rats
  • Respiratory Burst / drug effects*
  • Serum Albumin / pharmacology*
  • Tetradecanoylphorbol Acetate / analogs & derivatives
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Carbamates
  • Serum Albumin
  • Tumor Necrosis Factor-alpha
  • phorbolol myristate acetate
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • Tetradecanoylphorbol Acetate
  • Oxygen